CMG Pharmaceutical Co. Ltd
2 clinical trials · Sponsor
◉ Watch CMG Pharmaceutical Co. Ltd
| Record | Firm | Date |
|---|---|---|
| Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia (NCT06772168) | CMG Pharmaceutical Co. Ltd | 2024-04-19 |
Track CMG Pharmaceutical Co. Ltd automatically
Every clearance here is in the API, with alerts when new ones post.